Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (201-210 of 519) with videos related to

Pageof 52
Sort By:
The Lancet. Oncology|February 14, 2009
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial dataHoward I Scher, Xiaoyu Jia, Johann S de Bono, et al.
Urology|November 18, 2021
Advancements in the identification of EV derived mRNA biomarkers for liquid biopsy of clear cell renal cell carcinomasMorgan D Kuczler, Richard C Zieren, Liang Dong, et al.
Nature Reviews. Urology|October 12, 2016
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerationsJeffrey J Tosoian, Michael A Gorin, Ashley E Ross, et al.
Cancer|July 23, 2003
Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinomaDavid C Smith, Christopher H Chay, Rodney L Dunn, et al.
Biotechniques|July 13, 2016
A phased strategy to differentiate human CD14+monocytes into classically and alternatively activated macrophages and dendritic cellsJelani C Zarif, James R Hernandez, James E Verdone, et al.
Cancer|February 25, 2023
Bone marrow niche chemoprotection of metastatic solid tumors mediated by CYP3A4Gabriel Ghiaur, Kenneth C Valkenburg, Christopher Esteb, et al.
Clinical & Experimental Metastasis|February 28, 2019
The role of heterogeneous environment and docetaxel gradient in the emergence of polyploid, mesenchymal and resistant prostate cancer cellsKe-Chih Lin, Gonzalo Torga, Yusha Sun, et al.
BMC Systems Biology|March 12, 2014
A bioinformatics approach reveals novel interactions of the OVOL transcription factors in the regulation of epithelial - mesenchymal cell reprogramming and cancer progressionHernan Roca, Manjusha Pande, Jeffrey S Huo, et al.
Journal of Cellular Biochemistry|April 5, 2014
Niche inheritance: a cooperative pathway to enhance cancer cell fitness through ecosystem engineeringKimberline R Yang, Steven M Mooney, Jelani C Zarif, et al.
Oncotarget|August 29, 2015
Coupling the modules of EMT and stemness: A tunable 'stemness window' modelMohit Kumar Jolly, Dongya Jia, Marcelo Boareto, et al.
Pageof 52

Showing results (201-210 of 519) with videos related to

Sort By:
Pageof 52
The Lancet. Oncology|February 14, 2009
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial dataHoward I Scher, Xiaoyu Jia, Johann S de Bono, et al.
Urology|November 18, 2021
Advancements in the identification of EV derived mRNA biomarkers for liquid biopsy of clear cell renal cell carcinomasMorgan D Kuczler, Richard C Zieren, Liang Dong, et al.
Nature Reviews. Urology|October 12, 2016
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerationsJeffrey J Tosoian, Michael A Gorin, Ashley E Ross, et al.
Cancer|July 23, 2003
Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinomaDavid C Smith, Christopher H Chay, Rodney L Dunn, et al.
Biotechniques|July 13, 2016
A phased strategy to differentiate human CD14+monocytes into classically and alternatively activated macrophages and dendritic cellsJelani C Zarif, James R Hernandez, James E Verdone, et al.
Cancer|February 25, 2023
Bone marrow niche chemoprotection of metastatic solid tumors mediated by CYP3A4Gabriel Ghiaur, Kenneth C Valkenburg, Christopher Esteb, et al.
Clinical & Experimental Metastasis|February 28, 2019
The role of heterogeneous environment and docetaxel gradient in the emergence of polyploid, mesenchymal and resistant prostate cancer cellsKe-Chih Lin, Gonzalo Torga, Yusha Sun, et al.
BMC Systems Biology|March 12, 2014
A bioinformatics approach reveals novel interactions of the OVOL transcription factors in the regulation of epithelial - mesenchymal cell reprogramming and cancer progressionHernan Roca, Manjusha Pande, Jeffrey S Huo, et al.
Journal of Cellular Biochemistry|April 5, 2014
Niche inheritance: a cooperative pathway to enhance cancer cell fitness through ecosystem engineeringKimberline R Yang, Steven M Mooney, Jelani C Zarif, et al.
Oncotarget|August 29, 2015
Coupling the modules of EMT and stemness: A tunable 'stemness window' modelMohit Kumar Jolly, Dongya Jia, Marcelo Boareto, et al.
Pageof 52